All lobbying filings

AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION

Lobbying for AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 21, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Illinois

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Budget/Appropriations

- OMB: Signed on ASM Letter RE: Regulation for Federal Financial Assistance Proposed Rule (OMB-2026-0034). - US Senate: SUNucate Coalition Letter to Senate Appropriations Committee leadership RE: Support for $40 million in Fiscal Year 2027 funding for the Department of Defenses Melanoma Research Program.

Medicare/Medicaid

- US Senate: Signed on ASM Letter RE: Support for S. 5180, the Provider Reimbursement Stability Act. - CMS: Signed on ASM Letter RE: Medicare enrollment provisions in the Calendar Year 2027 Home Health Prospective Payment System Proposed Rule (CMS-1844-P). - CMS: Signed on ASM Letter RE: Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. - CMS: Signed on AADA Letter RE: Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. - CMS: Submitted ASDSA comments RE: Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule (CMS-1848-P).

Health Issues

-CMS and CDC: Submitted ASDSA comments RE: Clinical Laboratory Improvement Amendments (CLIA) Request for Information (CMS-3485-NC).

Bills named in this filing 1

S. 5180
Provider Reimbursement Stability Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.